Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 134.430
- -2.860-2.08%
Close Jan 8 16:00 ET
- 135.530
- +1.100+0.82%
Post 18:19 ET
8.04BMarket Cap-17.43P/E (TTM)
138.650High133.820Low500.34KVolume136.480Open137.290Pre Close67.87MTurnover0.84%Turnover RatioLossP/E (Static)59.81MShares161.00052wk High-79.88P/B7.98BFloat Cap111.09052wk Low--Dividend TTM59.37MShs Float183.980Historical High--Div YieldTTM3.52%Amplitude11.920Historical Low135.657Avg Price1Lot Size
Ascendis Pharma A/S Stock Analyst Ratings & Price Target
Price Target
Updated: Jan 7, 2025
The average Ascendis Pharma A/S stock price target is 194.00 with a max estimate of 289.00 and a min estimate of 153.00
Review Ascendis Pharma A/S earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Jan 7, 2025